TGFB1 and neoplasm: The application of precision oncology and genomic approaches can assist in determining the molecular events underpinning FP tumor development, and enable the rational design of novel therapeutic interventions (such as pharmacological disruption of MAPK and TGFβ oncogenic signaling) and clinical management strategies.